Dow, Sangamo Reach Research Milestones

Avatar para Matt Hopkins Por Scott C. Lucas|21 de junho de 2007

Dan Kittle, vice president, Research and Development for Dow AgroSciences, said, “These milestones demonstrate the ability of ZFP Nucleases (ZFNsTM) to act precisely at their intended target in canola and corn.” He added that this development has potentially significant impact on the cost and timelines of generating crop products with new and improved traits. In addition, Sangamo’s technology holds the potential to enable gene editing of native traits and up- and down-regulation of genes to influence metabolic profiles of plants.

The three-year agreement, which began in October 2005, provides Dow AgroSciences with access to Sangamo’s proprietary ZFP technology for the development of products in plants and plant cell cultures. During the initial three-year research term, Dow AgroSciences has the option to obtain a commercial license to sell products incorporating or derived from plant cells generated using Sangamo’s ZFP technology, including agricultural crops, industrial products, and plant-derived biopharmaceuticals.

Ocultar imagem